Related Experiment Video
Updated: Jun 6, 2026

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets
Published on: March 1, 2024
DHX33 inhibitors induced transcriptional changes for a subset of genes in cancer cells
Xingshun Wang1, Yichu Fu2, Xiyu Tang3
1School of Health and Nursing, Yunnan Open University, Kunming, 650500, Yunnan, China.
Abstract:
RNA helicase DHX33 has been shown to regulate many genes involved in cancer development. Whether or not this depends on its helicase activity remains a question. Two previously developed small molecules, BCD38 and KY386, have been shown to inhibit DHX33 helicase activity in vitro. Of them, KY386 is more potent to inhibit cancer development in vitro and in vivo. In this study, BCD38 and KY386, were both used to evaluate gene transcriptional changes upon DHX33 helicase inhibition. The effect was then compared to that of DHX33 knockdown. What was found was that DHX33 inhibitors caused transcriptional changes for a subset of genes, which recapitulated DHX33 knockdown in human cancer cells, albeit with some discrepancy. DHX33 inhibitors selectively downregulated a subset of genes involved in cancer progression in vitro and in vivo. Our study for the first time reveals that specific targeting DHX33 helicase activity with small molecule inhibitors induced gene transcriptional changes, which mimicked the effect the DHX33 knockdown, implicating that the cellular functions of DHX33 is dependent on its helicase activity.
Insights
Small molecule inhibitors targeting RNA helicase DHX33 (RHA) activity mimic gene expression changes seen with DHX33 knockdown. This suggests DHX33
Area of Science:
- Molecular Biology
- Cancer Research
- Drug Discovery
Background:
- RNA helicase DHX33 (RHA) is implicated in cancer development.
- The role of DHX33's helicase activity in its cellular functions is not fully understood.
Purpose of the Study:
- To investigate whether DHX33's helicase activity is essential for its role in regulating gene transcription in cancer cells.
- To compare the effects of DHX33 helicase inhibition with DHX33 knockdown on gene expression.
Main Methods:
- Utilized small molecule inhibitors (BCD38 and KY386) targeting DHX33 helicase activity.
- Performed gene transcriptional profiling upon inhibitor treatment and compared with DHX33 knockdown data.
- Evaluated effects in human cancer cells in vitro and in vivo.
Main Results:
- DHX33 inhibitors induced transcriptional changes in a subset of genes, recapitulating DHX33 knockdown effects.
- Inhibitors selectively downregulated genes associated with cancer progression.
- Observed some discrepancies between inhibitor effects and knockdown, suggesting nuanced regulation.
Conclusions:
- Targeting DHX33 helicase activity with small molecules induces gene expression changes mimicking DHX33 knockdown.
- The cellular functions of DHX33 are dependent on its helicase activity.
- Small molecule inhibitors offer a viable strategy to study and potentially target DHX33 in cancer.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Epigenetic Regulation
X-chromosome...
Inhibition of Cdk Activity
Inhibition of CDK Activity
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Regulation of Angiogenesis and Blood Supply

